Segall Bryant & Hamill’s Usana Health Sciences USNA Stock Holding History

Segall Bryant & Hamill’s Portfolio USNA Stock Details USNA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$318K	Buy	+14,914	New	+$280K	﹤0.01%	582

Other funds holding USNA

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Pzena Investment Management New York $34.1B AUM 23.81% 1-Year Est. Return

Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return

NCM

Nantahala Capital Management New Canaan, Connecticut $3.01B AUM 119.46% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Creative Planning Overland Park, Kansas $171B AUM 24.68% 1-Year Est. Return

AQR Capital Management Greenwich, Connecticut $287B AUM 42.33% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Segall Bryant & Hamill's USNA Position: Q2 2026 in Review

Segall Bryant & Hamill opened a new position in Usana Health Sciences (USNA) in Q2 2026: 14,914 shares worth $318K. The stake represents ﹤0.01% of the portfolio and ranks #582 among its holdings.

138 funds tracked by Wall St. Rank hold USNA as of Q2 2026.

Segall Bryant & Hamill held 14,914 shares of Usana Health Sciences worth $318K as of Q2 2026.
Usana Health Sciences was a new Segall Bryant & Hamill position in Q2 2026.
Usana Health Sciences made up ﹤0.01% of Segall Bryant & Hamill's portfolio in Q2 2026, its #582 holding.
138 funds tracked by Wall St. Rank held Usana Health Sciences as of Q2 2026.

Based on Segall Bryant & Hamill's 13F filing for Q2 2026, filed 12 Aug 2026.